BRIEF published on 10/15/2025 at 20:30, 2 months 26 days ago GeNeuro Delays Half-Year Financial Report Release Financial Report Restructuring Biopharmaceutical GeNeuro Debt Moratorium
PRESS RELEASE published on 10/15/2025 at 20:25, 2 months 26 days ago Inside Information / Other news releases GeNeuro SA postpones the publication of June 30, 2025 half-yearly financial report to assess financial impacts of debt-restructuring moratorium extension. New date to be announced Financial Report Postponement Neurological Disorders GeNeuro SA Debt-restructuring Moratorium
BRIEF published on 09/26/2025 at 18:41, 3 months 14 days ago GeNeuro SA: Extension of the debt restructuring stay until 2026 Restructuring GeNeuro Neurological Diseases Composition Stay Geneva Court
PRESS RELEASE published on 09/26/2025 at 18:36, 3 months 14 days ago Inside Information / Other news releases GeNeuro SA extends its definitive debt-restructuring moratorium until January 27, 2026, to explore strategic options and continue developing treatments for neurodegenerative and autoimmune diseases Autoimmune Diseases GeNeuro SA Neurodegenerative Diseases Debt-restructuring Moratorium
BRIEF published on 07/16/2025 at 08:05, 5 months 26 days ago GeNeuro SA announces the liquidation of its French subsidiary Restructuring Liquidation GeNeuro Subsidiary Neurodegenerative
PRESS RELEASE published on 07/16/2025 at 08:00, 5 months 26 days ago Inside Information / Other news releases GeNeuro SA announces the liquidation of its French subsidiary GeNeuro Innovation SAS, part of the restructuring process. Court appointed liquidator SELARL MJ-Synergie Liquidation Restructuring Process GeNeuro SA GeNeuro Innovation SAS SELARL MJ-Synergie
BRIEF published on 06/30/2025 at 19:42, 6 months 10 days ago GeNeuro's Shareholders Approve All Resolutions at Extraordinary General Meeting Shareholder Approval Restructuring Extraordinary General Meeting GeNeuro Asset Monetization
PRESS RELEASE published on 06/30/2025 at 19:37, 6 months 10 days ago Inside Information / Other news releases GeNeuro announces approval of all resolutions proposed at Extraordinary General Meeting with 69.1% share capital representation. Jesús Martin-Garcia named Executive Chairman Shareholders EGM Resolutions GeNeuro Jesús Martin-Garcia
BRIEF published on 06/12/2025 at 22:47, 6 months 28 days ago GeNeuro SA: Judicial recovery for its French subsidiary Restructuring GeNeuro SA Judicial Recovery French Subsidiary Judicial Administrator
PRESS RELEASE published on 06/12/2025 at 22:42, 6 months 28 days ago Inside Information / Other news releases GeNeuro SA's French subsidiary GeNeuro Innovation SAS enters receivership proceedings amidst parent company's debt-restructuring efforts Autoimmune Diseases GeNeuro SA Neurodegenerative Diseases Debt-restructuring Receivership Proceedings
Published on 01/10/2026 at 05:10, 1 day 8 hours ago Sekur Private Data Ltd. Announces Non-Brokered Private Placement
Published on 01/10/2026 at 00:45, 1 day 12 hours ago Digi Power X Announces Entry into Settlement Agreement
Published on 01/09/2026 at 23:30, 1 day 13 hours ago Matador Technologies Announces Grant of Restricted Share Units to Management Team
Published on 01/09/2026 at 23:10, 1 day 14 hours ago Usha Resources and Totec Resources Provide Supplemental Disclosure for Qualifying Transaction
Published on 01/10/2026 at 21:25, 15 hours 47 minutes ago CATL Opens Middle East's Largest New Energy Aftermarket Facility in Riyadh
Published on 01/10/2026 at 13:05, 1 day ago SeaVerse Launches World's First AI Native Platform, "All in AI Native" Leads the Forward-Looking Revolution in AI Creation
Published on 01/09/2026 at 21:55, 1 day 15 hours ago Piramal Pharma Achieves Notable Score Increase on 2025 S&P Global Corporate Sustainability Assessment (CSA)
Published on 01/09/2026 at 18:36, 1 day 18 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 01/09/2026 at 18:19, 1 day 18 hours ago EQS-Adhoc: BayWa AG: Change in the Board of Management of BayWa AG
Published on 01/09/2026 at 18:30, 1 day 18 hours ago H2 2025 half yearly report on the liquidity agreement signed with the Gilbert Dupont brokerage firm
Published on 01/09/2026 at 17:45, 1 day 19 hours ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 01/09/2026 at 17:42, 1 day 19 hours ago Aéroports de Paris SA - Shares and voting rights as of 31 December 2025
Published on 01/08/2026 at 21:00, 2 days 16 hours ago Biannual report on SEB S.A.’S liquidity agreement
